Secondary malignancy after treatment of Hodgkin's disease: An evolving picture

C. N. Coleman

Research output: Contribution to journalArticlepeer-review

Abstract

The following questions regarding secondary ANLL, which were raised a number of years ago, are being answered. Is the type of chemotherapy used important? Does radiotherapy add to the risk of chemotherapy? Is the age of the patient at the time of treatment an important risk factor?

Original languageEnglish (US)
Pages (from-to)821-824
Number of pages4
JournalJournal of Clinical Oncology
Volume4
Issue number6
DOIs
StatePublished - Jan 1 1986

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Secondary malignancy after treatment of Hodgkin's disease: An evolving picture'. Together they form a unique fingerprint.

Cite this